| Product Code: ETC7647070 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel CAR T-Cell Immunotherapy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel CAR T-Cell Immunotherapy Market - Industry Life Cycle |
3.4 Israel CAR T-Cell Immunotherapy Market - Porter's Five Forces |
3.5 Israel CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.8 Israel CAR T-Cell Immunotherapy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Israel CAR T-Cell Immunotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing investments in research and development in the field of CAR-T cell therapy |
4.2.3 Favorable government regulations and policies supporting the adoption of immunotherapy |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CAR-T cell therapy |
4.3.2 Limited awareness and understanding of CAR-T cell therapy among healthcare professionals and patients |
4.3.3 Challenges related to manufacturing scalability and logistics in the Israeli market |
5 Israel CAR T-Cell Immunotherapy Market Trends |
6 Israel CAR T-Cell Immunotherapy Market, By Types |
6.1 Israel CAR T-Cell Immunotherapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Allogeneic CAR T-Cells, 2021- 2031F |
6.1.4 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Autologous CAR T-Cells, 2021- 2031F |
6.2 Israel CAR T-Cell Immunotherapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Diffuse Large B-Cell Lymphoma, 2021- 2031F |
6.2.3 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.3 Israel CAR T-Cell Immunotherapy Market, By Target Antigen |
6.3.1 Overview and Analysis |
6.3.2 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By CD19, 2021- 2031F |
6.3.3 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By CD22, 2021- 2031F |
6.4 Israel CAR T-Cell Immunotherapy Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Israel CAR T-Cell Immunotherapy Market Revenues & Volume, By Diagnostic Center, 2021- 2031F |
7 Israel CAR T-Cell Immunotherapy Market Import-Export Trade Statistics |
7.1 Israel CAR T-Cell Immunotherapy Market Export to Major Countries |
7.2 Israel CAR T-Cell Immunotherapy Market Imports from Major Countries |
8 Israel CAR T-Cell Immunotherapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies related to CAR-T cell therapy in Israel |
8.2 Rate of adoption of CAR-T cell therapy in different types of cancer within the Israeli healthcare system |
8.3 Patient outcomes and survival rates post CAR-T cell therapy treatment |
9 Israel CAR T-Cell Immunotherapy Market - Opportunity Assessment |
9.1 Israel CAR T-Cell Immunotherapy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel CAR T-Cell Immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel CAR T-Cell Immunotherapy Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.4 Israel CAR T-Cell Immunotherapy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Israel CAR T-Cell Immunotherapy Market - Competitive Landscape |
10.1 Israel CAR T-Cell Immunotherapy Market Revenue Share, By Companies, 2024 |
10.2 Israel CAR T-Cell Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here